|
MGAT4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.865600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.217600E-01 |
| Normal-vs-Stage2 |
3.366400E-01 |
| Normal-vs-Stage3 |
1.485780E-01 |
| Normal-vs-Stage4 |
6.964700E-03 |
| Stage1-vs-Stage2 |
4.175400E-01 |
| Stage1-vs-Stage3 |
1.043160E-01 |
| Stage1-vs-Stage4 |
5.082700E-03 |
| Stage2-vs-Stage3 |
7.188800E-01 |
| Stage2-vs-Stage4 |
1.139760E-01 |
| Stage3-vs-Stage4 |
1.746980E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.233800E-01 |
| Normal-vs-AfricanAmerican |
3.584800E-01 |
| Normal-vs-Asian |
9.120000E-02 |
| Caucasian-vs-AfricanAmerican |
9.358000E-02 |
| Caucasian-vs-Asian |
2.715800E-01 |
| AfricanAmerican-vs-Asian |
2.301900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.753010E-01 |
| Normal-vs-Female |
3.762800E-01 |
| Male-vs-Female |
3.651400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.272400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.572400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.122100E-02 |
| Normal-vs-Age(81-100Yrs) |
7.298000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.106600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.630150E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.153400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.506850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.732200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.965000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.256300E-02 |
| Classical-VS-Follicular |
1.190380E-02 |
| Classical-VS-Other |
2.872800E-01 |
| Classical-VS-Normal |
8.450600E-01 |
| Tall-VS-Follicular |
5.786600E-01 |
| Tall-VS-Other |
9.083200E-01 |
| Tall-VS-Normal |
2.798000E-02 |
| Follicular-VS-Other |
8.432400E-01 |
| Follicular-VS-Normal |
5.842400E-02 |
| Other-VS-Normal |
2.414600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.361200E-01 |
| Normal-vs-N1 |
2.330200E-02 |
| N0-vs-N1 |
1.525020E-01 |
|
|
